Literature DB >> 30177296

X-linked Charcot-Marie-Tooth disease type 5 with recurrent weakness after febrile illness.

Noriko Nishikura1, Takanori Yamagata2, Takao Morimune3, Jun Matsui3, Tatsuyuki Sokoda3, Chihiro Sawai3, Yuko Sakaue3, Yujiro Higuchi4, Akihiro Hashiguchi4, Hiroshi Takashima4, Yoshihiro Takeuchi3, Yoshihiro Maruo3.   

Abstract

X-linked Charcot-Marie-Tooth disease type 5 (CMTX5) is an X-linked disorder characterized by early-onset sensorineural hearing impairment, peripheral neuropathy, and progressive optic atrophy. It is caused by a loss-of-function mutation in the phosphoribosyl pyrophosphate synthetase 1 gene (PRPS1), which encodes isoform I of phosphoribosyl pyrophosphate synthetase (PRS-I). A decreased activity leads to nonsyndromic sensorineural deafness (DFN2), CMTX5, and Arts syndrome depending upon residual PRS-I activity. Clinical and neurophysiological features of pediatric CMTX5 are poorly defined. We report two male siblings with peripheral neuropathy and prelingual sensorineural hearing loss who carried a novel c.319A>G (p.Ile107Val) PRPS1 missense mutation. They exhibited recurrent episodes of transient proximal muscle weakness, showing Gowers' sign and waddling gait after suffering from febrile illness. This transient weakness has not been previously reported in CMTX5. A patient with Arts syndrome was reported to have transient proximal weakness after febrile illness. The transient weakness presenting in both CMTX5 and Arts syndrome suggests an overlap of signs and a continuous spectrum of PRS-I hypoactivity disease. Children presenting with transient neurological signs should be evaluated for peripheral neuropathy and consider genetic analysis for PRPS1.
Copyright © 2018 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute weakness; Charcot–Marie–Tooth disease; Hearing impairment; PRPS1 gene

Mesh:

Substances:

Year:  2018        PMID: 30177296     DOI: 10.1016/j.braindev.2018.08.006

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  4 in total

1.  Hearing loss in inherited peripheral neuropathies: Molecular diagnosis by NGS in a French series.

Authors:  Justine Lerat; Corinne Magdelaine; Anne-Françoise Roux; Léa Darnaud; Hélène Beauvais-Dzugan; Steven Naud; Laurence Richard; Paco Derouault; Karima Ghorab; Laurent Magy; Jean-Michel Vallat; Pascal Cintas; Eric Bieth; Marie-Christine Arne-Bes; Cyril Goizet; Caroline Espil-Taris; Hubert Journel; Annick Toutain; Jon Andoni Urtizberea; Odile Boespflug-Tanguy; Fanny Laffargue; Philippe Corcia; Laurent Pasquier; Mélanie Fradin; Sylva Napuri; Jonathan Ciron; Jean-Marc Boulesteix; Franck Sturtz; Anne-Sophie Lia
Journal:  Mol Genet Genomic Med       Date:  2019-08-08       Impact factor: 2.183

2.  New PRPS1 variant p.(Met68Leu) located in the dimerization area identified in a French CMTX5 patient.

Authors:  Justine Lerat; Corinne Magdelaine; Paco Derouault; Hélène Beauvais-Dzugan; Eric Bieth; Blandine Acket; Marie-Christine Arne-Bes; Franck Sturtz; Anne-Sophie Lia
Journal:  Mol Genet Genomic Med       Date:  2019-07-23       Impact factor: 2.183

Review 3.  Contribution of Model Organisms to Investigating the Far-Reaching Consequences of PRPP Metabolism on Human Health and Well-Being.

Authors:  Eziuche A Ugbogu; Lilian M Schweizer; Michael Schweizer
Journal:  Cells       Date:  2022-06-13       Impact factor: 7.666

4.  A Novel PRPS1 Mutation in a Japanese Patient with CMTX5.

Authors:  Shunichi Shirakawa; Tatsufumi Murakami; Akihiro Hashiguchi; Hiroshi Takashima; Hiroshi Hasegawa; Kimiyoshi Ichida; Yoshihide Sunada
Journal:  Intern Med       Date:  2021-11-20       Impact factor: 1.282

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.